IRINOTECAN Labatec 300 mg/15ml flac
7680592840036
CH-59284
L01XX19
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 5928403
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- irinotecani hydrochloridum trihydricum 300 mg, sorbitolum 675 mg, acidum lacticum, acidum hydrochloricum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 15 ml corresp. natrium 34.49 mg.
Articles (1)
Irinotecan Labatec 300 mg/15 ml, solution à diluer pour perfusion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
irinotecani hydrochloridum trihydricum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
sorbitolum
|
675.0 MG | Substance | HBESI |
|
acidum lacticum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
34.49 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 283.55
Specialties list
Yes
Generic
Yes
SL addition date:
01/08/2012
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 59284
- Drug name
- Irinotecan Labatec, solution à diluer pour perfusion
- Galenic form
- KOPA
- ATC Code
- L01XX19
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 04/12/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IRINOTECAN Labatec 300 mg/15ml flac
- Description (DE)
- IRINOTECAN Labatec 300 mg/15ml Durchstf
- Market launch
- 15/03/2012
- Narcotic (BTM)
- No